Avidity Biosciences (RNA) has agreed to be acquired by Novartis (NVS) for $72 per share in a deal th
PREMIUM
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.
Upgrade
Already have a subscription? Sign in
Novartis to Acquire Avidity Biosciences for $72 per Share
Published 1 week ago
Oct 27, 2025 at 8:31 AM
Positive
Auto